Enfield, CT, United States of America

David F Bruton

USPTO Granted Patents = 9 

Average Co-Inventor Count = 9.0

ph-index = 8

Forward Citations = 301(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
9 patents (USPTO):Explore Patents

Title: David F Bruton: Innovator in Cell Culture Technology

Introduction

David F Bruton is a notable inventor based in Enfield, CT (US), recognized for his contributions to the field of cell culture technology. With a total of 9 patents, he has made significant advancements in the production of recombinant proteins, particularly antibodies, in mammalian cell cultures.

Latest Patents

Among his latest patents, Bruton has developed a modified serum-free cell culture medium. This invention describes improved methods and compositions for producing recombinant proteins, such as antibodies, in mammalian cell culture. Additionally, it provides enhanced cell culture media, including production media, feed solutions, and combination feeds, aimed at improving protein productivity in mammalian cell culture. Another significant patent focuses on methods of producing adalimumab, further showcasing his expertise in optimizing recombinant protein production.

Career Highlights

Bruton has had a distinguished career, working with prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the biotechnology sector.

Collaborations

Throughout his career, Bruton has collaborated with talented individuals, including Itzcoatl A Pla and John C Fann. These partnerships have fostered a collaborative environment that has led to the development of innovative solutions in cell culture technology.

Conclusion

David F Bruton stands out as a key figure in the field of cell culture technology, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing biotechnology. His work continues to influence the production of recombinant proteins, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…